//

Cover the Latest Developments in Allergy and Clinical Immunology at the EAACI Congress 2024 in Valencia, Spain

EAACI Congress 2024 https://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 VALENCIA, Spain, March 19, 2024 (GLOBE NEWSWIRE) — The European Academy of Allergy and Clinical Immunology (EAACI), with a membership of over 16,000 from 125 countries, annually orchestrates its congress to unveil the latest research and innovative advancements

//

Latest Quantexa Decision Intelligence Platform Roadmap Puts Focus on Helping Enterprises and Government Agencies to Get Data Ready For AI

   Quantexa supporting rising wave of organizations using data, analytics, and AI to break down silos Partnership with Microsoft makes Quantexa’s Decision Intelligence Platform immediately available on Microsoft Azure Marketplace; company commits to build solutions natively on Azure Technology preview demonstrates Quantexa’s

//

Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners

Proposed divestiture of Endpoint Clinical and Fortrea Patient Access businesses further streamlines Fortrea’s strategic focus as a pure-play contract research organization Creates standalone best-in-class Randomization and Trial Supply Management and Patient Access solutions positioned for differentiation and growth DURHAM, N.C., March 11,